Oral VK2735
VK2735 for Weight Management Phase 2 (Venture Oral Dosing)
Viking Therapeutics · Phase 2 · Completed · Enrollment 280
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Oral VK2735
Viking Therapeutics · Phase 2 · Completed · Enrollment 280
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.